Overview

Pharmacokinetic Non-interaction Study With a Fixed-dose Combination Tablet With Tramadol and Diclofenac

Status:
Completed
Trial end date:
2015-06-23
Target enrollment:
Participant gender:
Summary
The objective of the study was to evaluate whether or not there is a substantial pharmacokinetic interaction between diclofenac and tramadol in a new formulation of a fixed-dose combination of diclofenac 25 milligrams (mg) and tramadol 25 mg for oral administration. The study was conducted in healthy participants of both genders.
Phase:
Phase 1
Details
Lead Sponsor:
Grünenthal GmbH
Collaborators:
Grünenthal Colombiana S.A.
Grünenthal S.A.
Treatments:
Diclofenac
Tramadol